Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 16006751)

Published in Oncology on July 04, 2005

Authors

Naomi Konishi1, Chikao Miki, Toshimichi Yoshida, Koji Tanaka, Yuji Toiyama, Masato Kusunoki

Author Affiliations

1: Second Department of Surgery, Mie University School of Medicine, 2-174 Edobashi, Tsu, Japan.

Articles citing this

Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med (2006) 1.98

Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. Nat Commun (2011) 1.49

Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis. Cancer Prev Res (Phila) (2010) 1.12

Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease. Front Immunol (2013) 1.11

Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer. Br J Cancer (2010) 0.89

Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-κB and upregulation of IL-1Ra in melanoma model. PLoS One (2012) 0.86

Suppression of tumorigenesis: modulation of inflammatory cytokines by oral administration of microencapsulated probiotic yogurt formulation. Int J Inflam (2010) 0.79

Effects of ginsenoside Rb₁ on skin changes. J Biomed Biotechnol (2012) 0.79

Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes. Bioimpacts (2014) 0.78

Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells. Br J Cancer (2010) 0.78

Modulation of IL-1β reprogrammes the tumor microenvironment to interrupt oral carcinogenesis. Sci Rep (2016) 0.77

Seminal plasma induces the expression of IL-1α in normal and neoplastic cervical cells via EP2/EGFR/PI3K/AKT pathway. J Mol Signal (2014) 0.77

Tributyltin exposure alters cytokine levels in mouse serum. J Immunotoxicol (2016) 0.75

Effect of serum interleukin-1 receptor antagonist level on survival of patients with non-small cell lung cancer. Mol Clin Oncol (2017) 0.75

Articles by these authors

An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res (2006) 5.52

Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst (2013) 4.03

Trocar site hernia. Arch Surg (2004) 3.29

Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J Clin Invest (2004) 2.76

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut (2012) 2.40

Prognostic significance of host- and tumor-related factors in patients with gastric cancer. World J Surg (2010) 1.95

Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol (2003) 1.95

Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol (2009) 1.89

Laparoscopic lymphatic mapping and sentinel node biopsies for early-stage gastric cancer: the cause of false negativity. World J Surg (2005) 1.75

Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer. Oncology (2012) 1.66

Assessing myocardial perfusion with the transthoracic Doppler technique in patients with reperfused anterior myocardial infarction: comparison with angiographic, enzymatic and electrocardiographic indices. Eur Heart J (2004) 1.62

Tenascin-C synthesized in both donor grafts and recipients accelerates artery graft stenosis. Cardiovasc Res (2007) 1.48

Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol (2005) 1.46

Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Ann Surg (2014) 1.46

Leukocyte removal therapy for ulcerative colitis does not affect postoperative complications. J Gastroenterol (2006) 1.46

Method of cell transplantation promoting the organization of intraarterial thrombus. Circulation (2005) 1.40

Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer. Int J Cancer (2011) 1.39

Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg (2013) 1.38

Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion. Int J Exp Pathol (2004) 1.33

KAP1 is associated with peritoneal carcinomatosis in gastric cancer. Ann Surg Oncol (2009) 1.32

The development of MML (Medical Markup Language) version 3.0 as a medical document exchange format for HL7 messages. J Med Syst (2004) 1.31

Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol (2008) 1.31

The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer. PLoS One (2012) 1.26

Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin Cancer Res (2012) 1.25

Bioresorbable hyaluronate-carboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial. Surg Today (2005) 1.23

Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1. Int J Cancer (2003) 1.21

Effect of recanalization of chronic total occlusions on global and regional left ventricular function in patients with or without previous myocardial infarction. Catheter Cardiovasc Interv (2003) 1.19

Operative morbidity associated with groin dissections. Surg Today (2004) 1.19

A crucial role of mitochondrial Hsp40 in preventing dilated cardiomyopathy. Nat Med (2005) 1.19

Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer. Clin Cancer Res (2006) 1.18

Surgical management of axis' traumatic spondylolisthesis (Hangman's fracture). Arq Neuropsiquiatr (2004) 1.16

Tenascin-C is a useful marker for disease activity in myocarditis. J Pathol (2002) 1.16

Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells. Am J Pathol (2011) 1.16

Successful treatment of refractory hepatic lymphorrhea after gastrectomy for early gastric cancer, using surgical ligation and subsequent OK-432 (Picibanil) sclerotherapy. Gastric Cancer (2004) 1.15

C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci (2004) 1.14

Involvement of large tenascin-C splice variants in breast cancer progression. Am J Pathol (2003) 1.12

Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients. Int J Cancer (2009) 1.11

Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol (2002) 1.10

Electrochemical hydrogenation of [Ru(bpy)2(napy-kappaN)(CO)]2+: inhibition of reductive Ru--CO bond cleavage by a ruthenacycle. Angew Chem Int Ed Engl (2005) 1.10

Comparison of long-term results between laparoscopy-assisted gastrectomy and open gastrectomy with D2 lymph node dissection for advanced gastric cancer. Surg Endosc (2011) 1.10

Imaging neutrophil extracellular traps in the alveolar space and pulmonary capillaries of a murine sepsis model by multiphoton microscopy. Am J Respir Crit Care Med (2015) 1.09

Intravital imaging of DSS-induced cecal mucosal damage in GFP-transgenic mice using two-photon microscopy. J Gastroenterol (2010) 1.09

Association between recurrent metastasis from stage II and III primary colorectal tumors and moderate microsatellite instability. Gastroenterology (2012) 1.09

Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2010) 1.08

Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation. Thromb Haemost (2010) 1.07

Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. J Am Coll Cardiol (2006) 1.07

The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients. Surg Today (2006) 1.06

Acid-base equilibria of various oxidation states of aqua-ruthenium complexes with 1,10-phenanthroline-5,6-dione in aqueous media. Dalton Trans (2004) 1.06

Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol (2007) 1.05

Anatomical study of the perforators from the ulnar palmar digital artery of the little finger and clinical uses of digital artery perforator flaps. Scand J Plast Reconstr Surg Hand Surg (2009) 1.05

Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation. J Cardiovasc Pharmacol (2007) 1.05

C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery. Anticancer Res (2013) 1.04

Thrombin-cleaved osteopontin levels in synovial fluid correlate with disease severity of knee osteoarthritis. J Rheumatol (2010) 1.04

Feasibility of a lateral region sentinel node biopsy of lower rectal cancer guided by indocyanine green using a near-infrared camera system. Ann Surg Oncol (2009) 1.03

The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. Differentiation (2003) 1.03

Radiation induces epithelial-mesenchymal transition in colorectal cancer cells. Oncol Rep (2011) 1.03

CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer. Eur J Cancer (2011) 1.03

Outcome of surgical resection for recurrent pulmonary metastasis from colorectal carcinoma. Am J Surg (2011) 1.02

A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4. J Biol Chem (2007) 1.02

Teratoid Wilms' tumor: a case report with literature review. J Pediatr Surg (2006) 1.02

Intravital three-dimensional dynamic pathology of experimental colitis in living mice using two-photon laser scanning microscopy. J Gastrointest Surg (2011) 1.01

Tenascin-C enhances crosstalk signaling of integrin αvβ3/PDGFR-β complex by SRC recruitment promoting PDGF-induced proliferation and migration in smooth muscle cells. J Cell Physiol (2011) 1.01

Superior mesenteric artery syndrome in an infant: case report and literature review. J Pediatr Surg (2007) 0.99

Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer. J Vasc Interv Radiol (2005) 0.99

Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy. Int J Oncol (2011) 0.99

Impact of surgical site infection after colorectal surgery on hospital stay and medical expenditure in Japan. Surg Today (2012) 0.99

Site-specific patterns of surgical site infections and their early indicators after elective colorectal cancer surgery. Dis Colon Rectum (2006) 0.99